Humoral immunity and transcriptome differences of COVID-19 inactivated vacciane and protein subunit vaccine as third booster dose in human

Humoral immunity and transcriptome differences of COVID-19 inactivated vacciane and protein subunit vaccine as third booster dose in human

Under the background of the severe human health and world economic burden caused by COVID-19, the attenuation of vaccine protection efficacy, and the prevalence and immune escape of emerging variants of concern (VOCs), the third dose of booster immunization has been put on the agenda. Systems biolog...

Full description

Bibliographic Details
Main Authors:	Yuwei Zhang, Mingxiao Yao, Xingyu Guo, Shanshan Han, Shu Zhang, Jinzhong Zhang, Xiangkun Jiang, Jianxing Wang, Ming Fang, Shuang Wang, Bo Pang, Xiaolin Liu, Zengqiang Kou, Xiaolin Jiang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Series:	Frontiers in Immunology
Subjects:	COVID-19 third booster vaccine variants of concern humoral immunity transcriptome analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.1027180/full

Similar Items

Antibody and transcription landscape in peripheral blood mononuclear cells of elderly adults over 70 years of age with third dose of COVID-19 BBIBP-CorV and ZF2001 booster vaccine
by: Yuwei Zhang, et al.
Published: (2024-01-01)

Humoral and cellular immunogenicity of COVID-19 booster dose vaccination in inflammatory arthritis patients
by: Jakub Wroński, et al.
Published: (2022-10-01)

The Kinetics of Humoral and Cellular Responses after the Booster Dose of COVID-19 Vaccine in Inflammatory Arthritis Patients
by: Jakub Wroński, et al.
Published: (2023-02-01)

Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adultsResearch in context
by: Constanza Méndez, et al.
Published: (2023-05-01)

SARS-CoV-2 booster vaccine dose significantly extends humoral immune response half-life beyond the primary series
by: Chapin S. Korosec, et al.
Published: (2024-04-01)

Homologous or Heterologous COVID-19 Booster Regimens Significantly Impact Sero-Neutralization of SARS-CoV-2 Virus and Its Variants
by: Rome Buathong, et al.
Published: (2022-08-01)

Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection
by: Hakjun Hyun, et al.
Published: (2023-03-01)

A longitudinal study of humoral immune responses induced by a 3-dose inactivated COVID-19 vaccine in an observational, prospective cohort
by: Yue Tao, et al.
Published: (2022-11-01)

Adult Patients with Cancer Have Impaired Humoral Responses to Complete and Booster COVID-19 Vaccination, Especially Those with Hematologic Cancer on Active Treatment: A Systematic Review and Meta-Analysis
by: Efstathia Liatsou, et al.
Published: (2023-04-01)

COVID-19 vaccine immunogenicity in 16 patients with autoimmune systemic diseases. Lack of both humoral and cellular response to booster dose and ongoing disease modifying therapies
by: Laura Gragnani, et al.
Published: (2022-01-01)

COVID-19 Vaccine Booster: To Boost or Not to Boost
by: Rahul Shekhar, et al.
Published: (2021-10-01)

Humoral immunity trends in a hemodialysis cohort following SARS‐CoV‐2 mRNA booster: A cohort study
by: Eibhlin Goggins, et al.
Published: (2024-02-01)

Increase over time of antibody levels 3 months after a booster dose as an indication of better protection against Omicron infection
by: Rea Bingula, et al.
Published: (2023-12-01)

Systematic Booster after Rabies Pre-Exposure Prophylaxis to Alleviate Rabies Antibody Monitoring in Individuals at Risk of Occupational Exposure
by: Perrine Parize, et al.
Published: (2021-03-01)

Heterologous Booster Immunization Based on Inactivated SARS-CoV-2 Vaccine Enhances Humoral Immunity and Promotes BCR Repertoire Development
by: Xinghang Li, et al.
Published: (2024-01-01)

Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China
by: Tao-Hsin Tung, et al.
Published: (2022-11-01)

Humor as a Political Act: Study of Indonesian Presidents’ Humor
by: Surahmat Surahmat, et al.
Published: (2023-03-01)

Immunocytometric analysis of patients with thymic epithelial tumors revealed that COVID-19 vaccine booster strongly enhanced the immune response
by: Gustavo Cernera, et al.
Published: (2023-08-01)

Immunogenicity and Safety of BNT162b2 Homologous Booster Vaccination in People Living with HIV under Effective cART
by: Laura Gianserra, et al.
Published: (2022-08-01)

The association between social media use and hesitancy toward COVID-19 vaccine booster shots in China: A web-based cross-sectional survey
by: Ruitong Wang, et al.
Published: (2022-11-01)

Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine
by: Sitthichai Kanokudom, et al.
Published: (2022-01-01)

Specific Cellular and Humoral Response after the Third Dose of Anti-SARS-CoV-2 RNA Vaccine in Patients with Immune-Mediated Rheumatic Diseases on Immunosuppressive Therapy
by: Kauzar Mohamed Mohamed, et al.
Published: (2023-08-01)

Evaluation of the Effect of a Recent Comparative Intradermal Tuberculin Test on the Humoral Diagnosis of Paratuberculosis Using Serum and Milk Samples from Goats
by: Carlos Velasco, et al.
Published: (2024-02-01)

Selective adaptation of SARS-CoV-2 Omicron under booster vaccine pressure: a multicentre observational studyResearch in context
by: Ralf Duerr, et al.
Published: (2023-11-01)

Individuals With Weaker Antibody Responses After Booster Immunization Are Prone to Omicron Breakthrough Infections
by: Birte Möhlendick, et al.
Published: (2022-06-01)

Immunity against Delta and Omicron variants elicited by homologous inactivated vaccine booster in kidney transplant recipients
by: Lei Zhang, et al.
Published: (2023-01-01)

Effectiveness of COVID-19 Vaccine Booster Shot Compared with Non-Booster: A Meta-Analysis
by: Yajuan Zhu, et al.
Published: (2022-08-01)

Comparison of Safety of Different Vaccine Boosters Following Two-Dose Inactivated Vaccines: A Parallel Controlled Prospective Study
by: Zhi-Qiang Lin, et al.
Published: (2022-04-01)

The psychology of humor : an integrative approach /
by: 287894 Martin, Rod A.
Published: (2007)

Vaccine Confidence and Uptake of the Omicron Bivalent Booster in Tennessee: Implications for Vulnerable Populations
by: Donald J. Alcendor, et al.
Published: (2023-04-01)

Sudden Sensorineural Hearing Loss after Third Dose Booster of COVID-19 Vaccine Administration
by: Federica Zoccali, et al.
Published: (2022-08-01)

Article review: Comparison of octane booster additive for gasoline
by: Gustiana Awaludin Sobarsah, et al.
Published: (2021-10-01)

Declined Humoral Immunity of Kidney Transplant Recipients to SARS-CoV-2 Vaccines
by: Mahallawi WH, et al.
Published: (2023-05-01)

The Relationship Between Humor Styles and Forgiveness
by: William Hampes
Published: (2016-08-01)

SARS‐CoV‐2 booster effect and waning immunity in hemodialysis patients: A cohort study
by: Eibhlin Goggins, et al.
Published: (2023-01-01)

Motivation in humor /
by: 285106 Levine, Jacob, et al.
Published: (2006)

American humor
by: Deniz Bozer
Published: (1991-12-01)

Development of Brake Booster Design for Electric City Cars
by: Afitro Adam Nugraha, et al.
Published: (2021-10-01)

Safety and immunogenicity of heterologous recombinant protein subunit vaccine (ZF2001) booster against COVID-19 at 3–9-month intervals following two-dose inactivated vaccine (CoronaVac)
by: Yuting Liao, et al.
Published: (2022-11-01)

Third BNT162b2 Vaccine Booster Dose against SARS-CoV-2-Induced Antibody Response among Healthcare Workers
by: Khetam Hussein, et al.
Published: (2022-10-01)